Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Hubei, People's Republic of China.
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
J Thorac Oncol. 2023 May;18(5):608-619. doi: 10.1016/j.jtho.2023.01.002. Epub 2023 Jan 18.
High-grade histologic patterns are associated with poor prognosis in patients with primary nonmucinous lung adenocarcinoma (ADC). We investigated whether the presence of micropapillary (MIP), solid (SOL), or both patterns in lymph node (LN) metastases has prognostic value.
Patients who underwent lobectomy for pathologic stages II to III lung ADC with N1 or N2 LN metastases (N = 360; 2000-2012) were analyzed. We assessed overall survival (OS), lung cancer-specific cumulative incidence of death (LC-CID), and cumulative incidence of recurrence (CIR) between patients with and without MIP/SOL patterns in LN metastases. Multivariable Cox regression analysis was used to quantify the association between MIP/SOL patterns and outcomes.
MIP and SOL in LN metastases were associated with a higher incidence of smoking history (p = 0.004), tumor necrosis (p = 0.013), and spread of tumor through air spaces (p < 0.0001), a higher prevalence of MIP or SOL in the primary tumor (p < 0.0001), shorter OS (5-y OS, 40% [95% confidence interval or CI: 29%-56%] versus 63% [48%-83%] for no MIP/SOL in LNs, p = 0.03), higher LC-CID (5-y, 43% [29%-56%] versus 14% [4%-29%], p = 0.013), and higher CIR (5-y, 65% [50%-77%] versus 43% [25%-60%], p = 0.057). MIP and SOL in LN metastases were independently associated with poor outcomes: OS (hazard ratio [HR] = 1.81 [95% CI: 1.00-3.29], p = 0.05), LC-CID (HR = 3.10 [1.30-7.37], p = 0.01), and CIR (HR = 2.06 [1.09-3.90], p = 0.026).
MIP/SOL histologic patterns in N1 or N2 LN metastases are associated with worse outcomes in patients with stages II to III lung ADC. MIP/SOL histologic patterns in LN metastases can stratify patients with high-risk stages II to III lung ADC.
高级别组织学模式与原发性非黏液性肺腺癌(ADC)患者的预后不良相关。我们研究了淋巴结(LN)转移中微乳头状(MIP)、实体(SOL)或两者模式的存在是否具有预后价值。
分析了 2000 年至 2012 年间接受肺 ADC 病理 II 至 III 期行肺叶切除术且存在 N1 或 N2 LN 转移的 360 例患者。我们评估了有无 LN 转移中 MIP/SOL 模式的患者之间的总生存(OS)、肺癌特异性累积死亡率(LC-CID)和累积复发率(CIR)。多变量 Cox 回归分析用于量化 MIP/SOL 模式与结局之间的关联。
LN 转移中的 MIP 和 SOL 与更高的吸烟史发生率(p=0.004)、肿瘤坏死(p=0.013)和肿瘤通过气腔播散(p<0.0001)相关,与原发肿瘤中 MIP 或 SOL 更普遍(p<0.0001)相关,与较短的 OS(5 年 OS,40%[95%置信区间或 CI:29%-56%]与无 LN 中 MIP/SOL 的 63%[48%-83%],p=0.03)相关,与更高的 LC-CID(5 年,43%[29%-56%]与 14%[4%-29%],p=0.013)相关,与更高的 CIR(5 年,65%[50%-77%]与 43%[25%-60%],p=0.057)相关。LN 转移中的 MIP 和 SOL 与不良结局独立相关:OS(风险比[HR]1.81[95% CI:1.00-3.29],p=0.05)、LC-CID(HR 3.10[1.30-7.37],p=0.01)和 CIR(HR 2.06[1.09-3.90],p=0.026)。
在 II 期至 III 期肺 ADC 患者中,N1 或 N2 LN 转移中的 MIP/SOL 组织学模式与预后不良相关。LN 转移中 MIP/SOL 组织学模式可对高危 II 期至 III 期肺 ADC 患者进行分层。